🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Massachusetts › Boston

Diffuse Intrinsic Pontine Glioma clinical trials in Boston, MA

9 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
  • Dana-Farber Cancer Institute, Boston
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Susan Chi, Boston
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Dana-Farber Cancer Institute, Boston
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

RecruitingPhase 2
  • Dana-Farber Cancer Institute Harvard University, Boston
Ages 2 to 39 · All sexes · Updated Jun 26, 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RecruitingEarly phase 1
  • Dana-Farber Cancer Institute, Boston
Up to age 21 · All sexes · Updated Mar 18, 2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

RecruitingPhase 1
  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
12 Months – 18 Years · All sexes · Updated Mar 17, 2026 · NCT04943848

Diffuse Intrinsic Pontine Glioma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.